1 Unstoppable Stock I'm Buying on the Dip for My Daughter's Portfolio in 2026

Chewy has materially strengthened its fundamentals since 2019—sales roughly quintupled, active customers increased from 10.6 million to 21.2 million, gross profit margins expanded by about 10 percentage points, and net income and free cash flow margins have turned positive—yet the stock trades roughly 32% below its 52-week high. Management is focusing on higher‑margin initiatives (Autoship optimization, Chewy Vet Care, private‑label Get Real, advertising and Chewy+) that could accelerate profitability and support a ~26x forward earnings multiple, even as recent top‑line growth decelerated to 8% in the last quarter versus ~20% annualized over the prior five years.

Analysis

Market structure: Chewy (CHWY) is positioned to capture share from traditional pet retail (WOOF, PETM) and generalists (AMZN) by monetizing higher-margin services (Autoship, vet care, advertising, private label). Active customers doubled to 21.2M since 2019, implying durable demand; a 32% share decline vs 52-week high suggests sentiment, not fundamentals, is driving price. Cross-asset: modest equity volatility lift in consumer discretionary names, limited FX/commodity impact aside from animal-protein and grain cost cycles; IG credit spreads for retail could widen modestly with a broader consumer slowdown.

Risk assessment: Tail risks include regulatory scrutiny of veterinary services/telehealth, data/privacy breaches, supply shocks for ingredient costs, or aggressive price competition from Amazon that compresses margins by >300bps. Immediate (days) risk: earnings/guide reaction; short-term (quarters) risk: execution of Autoship/Ads monetization; long-term (2+ years) risk: TAM saturation and LTV/CAC deterioration if retention falls. Hidden dependencies: reliance on 3PL/logistics and prescription pharmacy margins; macro-driven discretionary spend drop would disproportionately hit younger pet-owner cohorts.

Trade implications: Tactical long CHWY exposure favors idiosyncratic return if management proves sustained margin expansion (target: +200–400bps gross margin over 4 quarters). Pair trade: long CHWY vs short WOOF to isolate execution/online-share thesis. Options: sell 3–6 month 8–12% OTM cash-secured puts to collect premium if willing to own, or buy 12–18 month LEAP calls sized 25–40% of equity allocation to leverage positive secular trends.

Contrarian angles: Consensus underestimates the speed at which Autoship + private label can expand gross margin and ARPU; conversely, investors underprice a scenario where supplier pushback or regulatory limits on vet services slow monetization. Historical parallel: early Amazon/Wayfair mix-shift — execution differentiated winners from losers. Unintended consequence: rapid private-label rollout could trigger supplier delisting, leading to short-term assortment loss and customer churn if not managed.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in CHWY over the next 4 weeks, scaling into 1/3 now and the remainder on a pullback of 10%+ or on confirmation of sequential quarterly gross-margin improvement ≥100–200bps; set a hard stop-loss at 20% below average entry.
• Implement a relative-value pair: long CHWY (2% portfolio) and short WOOF (1.5%) to express Chewy-specific execution upside while hedging broad pet-retail/consumer discretionary beta over a 6–12 month horizon.
• If income/entry-price discipline preferred, sell cash-secured CHWY puts 8–12% OTM with 3–6 month expiries sized to convert to a 3% portfolio position if assigned; reassess if implied vol rises >40% vs historical 90-day vol.
• Buy CHWY 12–18 month LEAP calls sized to 25–40% of planned equity exposure to capture margin re-rating; exit or halve position if Autoship penetration and private-label contribution fail to show >150–200bps combined margin benefit after two consecutive quarters.